Wanye Hu

1.3k total citations · 1 hit paper
14 papers, 883 citations indexed

About

Wanye Hu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Wanye Hu has authored 14 papers receiving a total of 883 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Wanye Hu's work include Ferroptosis and cancer prognosis (8 papers), RNA modifications and cancer (6 papers) and Trace Elements in Health (2 papers). Wanye Hu is often cited by papers focused on Ferroptosis and cancer prognosis (8 papers), RNA modifications and cancer (6 papers) and Trace Elements in Health (2 papers). Wanye Hu collaborates with scholars based in China. Wanye Hu's co-authors include Yanchun Li, Jing Du, Ying Wang, Xiangmin Tong, Yi Zhou, Xueying Ren, Chaoting Zhou, Chen Yang, Qiangan Jing and Xu Wang and has published in prestigious journals such as Free Radical Biology and Medicine, Cell Death and Disease and Redox Biology.

In The Last Decade

Wanye Hu

14 papers receiving 883 citations

Hit Papers

Overcoming the compensatory elevation of NRF2 renders hep... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wanye Hu China 11 539 512 366 155 131 14 883
Tobias Seibt Germany 5 754 1.4× 858 1.7× 603 1.6× 105 0.7× 113 0.9× 8 1.3k
Qiangan Jing China 8 319 0.6× 308 0.6× 241 0.7× 128 0.8× 107 0.8× 13 586
Nen C. Pagano United States 5 840 1.6× 575 1.1× 457 1.2× 245 1.6× 74 0.6× 8 1.1k
Samantha Alvarez United States 7 919 1.7× 666 1.3× 595 1.6× 116 0.7× 81 0.6× 11 1.2k
Daniel J. Fridman Canada 5 901 1.7× 869 1.7× 651 1.8× 142 0.9× 93 0.7× 9 1.3k
Tomonori Tadokoro Japan 13 558 1.0× 424 0.8× 278 0.8× 233 1.5× 64 0.5× 23 1.1k
Erdem M. Terzi United States 5 648 1.2× 641 1.3× 485 1.3× 88 0.6× 78 0.6× 7 916
Guillaume Kugener United States 11 439 0.8× 199 0.4× 187 0.5× 149 1.0× 134 1.0× 22 846
Stephen L. Lessnick United States 4 990 1.8× 879 1.7× 643 1.8× 235 1.5× 74 0.6× 4 1.4k
Akihito Ishikita Japan 11 434 0.8× 318 0.6× 211 0.6× 120 0.8× 56 0.4× 19 799

Countries citing papers authored by Wanye Hu

Since Specialization
Citations

This map shows the geographic impact of Wanye Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanye Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanye Hu more than expected).

Fields of papers citing papers by Wanye Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanye Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanye Hu. The network helps show where Wanye Hu may publish in the future.

Co-authorship network of co-authors of Wanye Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Wanye Hu. A scholar is included among the top collaborators of Wanye Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanye Hu. Wanye Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Li, Sainan, Yingchao Liu, Wanye Hu, et al.. (2025). Protein lipoylation in cancer: metabolic reprogramming and therapeutic potential. Cell Death Discovery. 11(1). 420–420. 4 indexed citations
2.
Li, Yanchun, Xueying Ren, Chen Yang, et al.. (2024). GSH exhaustion via inhibition of xCT-GSH-GPX4 pathway synergistically enhanced DSF/Cu-induced cuproptosis in myelodysplastic syndromes. Free Radical Biology and Medicine. 222. 130–148. 22 indexed citations
3.
Zhang, Ping, Chaoting Zhou, Xueying Ren, et al.. (2023). Inhibiting the compensatory elevation of xCT collaborates with disulfiram/copper-induced GSH consumption for cascade ferroptosis and cuproptosis. Redox Biology. 69. 103007–103007. 69 indexed citations
4.
Hu, Jiayu, et al.. (2022). Fundamental Neurocircuit of Anti-inflammatory Effect by Electroacupuncture Stimulation Identified. Neuroscience Bulletin. 38(7). 837–839. 3 indexed citations
5.
Zhou, Chaoting, Luyang Wang, Wanye Hu, et al.. (2022). CDC25C is a prognostic biomarker and correlated with mitochondrial homeostasis in pancreatic adenocarcinoma. Bioengineered. 13(5). 13089–13107. 11 indexed citations
6.
Chen, Shida, Jing Yang, Yongran Cheng, et al.. (2022). Significance of Common Blood Test Indexes in the Diagnosis and Prognosis of Multiple Myeloma. Clinical Laboratory. 68(04/2022). 4 indexed citations
7.
Yang, Jing, Yi Zhou, Yanchun Li, et al.. (2022). Functional deficiency of succinate dehydrogenase promotes tumorigenesis and development of clear cell renal cell carcinoma through weakening of ferroptosis. Bioengineered. 13(4). 11187–11207. 28 indexed citations
8.
Yang, Chen, Yanchun Li, Wanye Hu, et al.. (2021). TEOA Promotes Autophagic Cell Death via ROS-Mediated Inhibition of mTOR/p70S6k Signaling Pathway in Pancreatic Cancer Cells. Frontiers in Cell and Developmental Biology. 9. 734818–734818. 18 indexed citations
9.
Hu, Wanye, Chaoting Zhou, Qiangan Jing, et al.. (2021). FTH promotes the proliferation and renders the HCC cells specifically resist to ferroptosis by maintaining iron homeostasis. Cancer Cell International. 21(1). 709–709. 77 indexed citations
10.
Du, Jing, Xu Wang, Yanchun Li, et al.. (2021). DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism. Cell Death and Disease. 12(7). 705–705. 138 indexed citations
11.
Li, Yanchun, Xin Wang, Zhihui Huang, et al.. (2021). CISD3 inhibition drives cystine-deprivation induced ferroptosis. Cell Death and Disease. 12(9). 839–839. 83 indexed citations
12.
Ren, Xueying, Yanchun Li, Yi Zhou, et al.. (2021). Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis. Redox Biology. 46. 102122–102122. 227 indexed citations breakdown →
13.
Shao, Fangchun, Yanchun Li, Wanye Hu, et al.. (2021). Downregulation of CISD2 Has Prognostic Value in Non-Small Cell Lung Cancer and Inhibits the Tumorigenesis by Inducing Mitochondrial Dysfunction. Frontiers in Oncology. 10. 595524–595524. 18 indexed citations
14.
Du, Jing, Yi Zhou, Yanchun Li, et al.. (2020). Identification of Frataxin as a regulator of ferroptosis. Redox Biology. 32. 101483–101483. 181 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026